4.4900
+4.4900
(-0.44%)
At close: January 24 at 4:00:01 PM EST
4.5000
+0.01
+(0.22%)
After hours: January 24 at 6:55:37 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.48M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.15 per share. | Indirect | 613,470 | Jul 30, 2024 |
| LEONARD BRADEN MICHAEL Beneficial Owner of more than 10% of a Class of Security | Purchase at price 7.75 - 9.11 per share. | Indirect | 1,785,662 | Jul 18, 2024 |
| LUPHER MARK L. JR., PH.D. Director | Purchase at price 1.35 per share. | Indirect | 175,500 | Feb 7, 2024 |
| SCOPA JAMES PAUL Director | Purchase at price 1.35 per share. | Direct | 135,000 | Feb 7, 2024 |
| SEYEDKAZEMI SETAREH Officer | Sale at price 1.52 - 1.55 per share. | Direct | 9,429 | Sep 15, 2023 |
| RUBINSTEIN LINDA M. Chief Financial Officer | Purchase at price 1.45 per share. | Direct | 145,490 | Jun 7, 2023 |
| FISCHER LAURENT D M.D. Chief Executive Officer | Sale at price 0.78 per share. | Direct | 32,232 | Mar 15, 2023 |
| SOPARKAR PETER Chief Operating Officer | Sale at price 0.78 per share. | Direct | 10,442 | Mar 15, 2023 |
| RILEY BRIGIT Officer | Sale at price 0.78 per share. | Direct | 5,705 | Mar 15, 2023 |
Related Tickers
FDMT 4D Molecular Therapeutics, Inc.
4.6600
-4.31%
AKTX Akari Therapeutics, Plc
1.1577
-1.05%
PSTV Plus Therapeutics, Inc.
1.2300
+1.65%
ANTX AN2 Therapeutics, Inc.
1.2500
0.00%
TENX Tenax Therapeutics, Inc.
6.54
-0.30%
FULC Fulcrum Therapeutics, Inc.
4.1600
+0.48%
MGTX MeiraGTx Holdings plc
6.21
+2.31%
CELZ Creative Medical Technology Holdings, Inc.
2.4300
+2.98%
PRQR ProQR Therapeutics N.V.
2.1600
-0.46%
RGLS Regulus Therapeutics Inc.
1.2400
+2.48%